Vol. 12, Special Issue 10 (2023)

Author(s):
Aabid Hussain Lone, Masood H Balkhi, Aadil Hussain Magloo, Rinkesh Nemichand Wanjari, Asim Iqbal Bazaz, Mudasir Ahmad Shah and Haziq Qayoom Lone

Abstract:
The growing interest in plant-based medicines, considered safer and more reliable ("green medicine"), is steering a paradigm shift in combatting infections, especially in aquaculture. Medicinal plants, acknowledged for their antibacterial properties, present a compelling alternative to synthetic antimicrobials, potentially alleviating their detrimental effects. Aquatic plants, especially seaweeds, are emerging as robust reservoirs of bioactive compounds, sparking interest in allelopathic research. Seaweeds, teeming with diverse bioactive compounds, hold immense promise for the development of functional ingredients and therapeutic drugs. Their sophisticated chemical defense mechanisms, honed to combat microbial threats, augur well in the battle against human and fish bacterial pathogens, as well as various diseases. This study meticulously focuses on appraising the antibacterial potential of unique extracts derived from the submerged aquatic plant Ceratophyllum demersum (Coontail) against clinical isolates of fish bacterial pathogens. The research endeavors to offer invaluable insights into leveraging aquatic plants as a natural remedy to combat bacterial diseases in fish, emphasizing the promotion of sustainable practices within the aquaculture industry.